Global Microbiomes Market Size, Status and Forecast 2020-2026

August 2020 | 128 pages | ID: G07F01BA05A0EN
QYResearch

Abstracts

Microbiomes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microbiomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• 4D Pharma
• Enterome BioScience
• Evelo Biosciences
• Ferring
• Osel
• Second Genome
• Seres Therapeutics
• Synlogic
• Synthetic Biologics and Vedanta Biosciences
• Vedanta
• Rebiotix
• ActoGeniX
• Enterologics
• Metabogen
• Metabiomics
• Ritter Pharmaceuticals
• AvidBiotics
• Symberix
• Miomics
• Symbiotix Biotherapies
• MicroBiome Therapeutics LLC
• SciBac Inc

Market segment by Type, the product can be split into

• Gastrointestinal Microbiome
• Genitourinary Microbiome
• Skin Microbiome
• Respiratory Microbiome
• Other

Market segment by Application, split into

• Testing
• Treatment
• Diagnosis
• Technology Platform
• Probiotics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Microbiomes Revenue
1.4 Market by Type
  1.4.1 Global Microbiomes Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gastrointestinal Microbiome
  1.4.3 Genitourinary Microbiome
  1.4.4 Skin Microbiome
  1.4.5 Respiratory Microbiome
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Microbiomes Market Share by Application: 2020 VS 2026
  1.5.2 Testing
  1.5.3 Treatment
  1.5.4 Diagnosis
  1.5.5 Technology Platform
  1.5.6 Probiotics
  1.5.7 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Microbiomes Market Perspective (2015-2026)
2.2 Global Microbiomes Growth Trends by Regions
  2.2.1 Microbiomes Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Microbiomes Historic Market Share by Regions (2015-2020)
  2.2.3 Microbiomes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Microbiomes Market Growth Strategy
  2.3.6 Primary Interviews with Key Microbiomes Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Microbiomes Players by Market Size
  3.1.1 Global Top Microbiomes Players by Revenue (2015-2020)
  3.1.2 Global Microbiomes Revenue Market Share by Players (2015-2020)
  3.1.3 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Microbiomes Market Concentration Ratio
  3.2.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2019
3.3 Microbiomes Key Players Head office and Area Served
3.4 Key Players Microbiomes Product Solution and Service
3.5 Date of Enter into Microbiomes Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Microbiomes Historic Market Size by Type (2015-2020)
4.2 Global Microbiomes Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Microbiomes Market Size by Application (2015-2020)
5.2 Global Microbiomes Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Microbiomes Market Size (2015-2020)
6.2 Microbiomes Key Players in North America (2019-2020)
6.3 North America Microbiomes Market Size by Type (2015-2020)
6.4 North America Microbiomes Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Microbiomes Market Size (2015-2020)
7.2 Microbiomes Key Players in Europe (2019-2020)
7.3 Europe Microbiomes Market Size by Type (2015-2020)
7.4 Europe Microbiomes Market Size by Application (2015-2020)

8 CHINA

8.1 China Microbiomes Market Size (2015-2020)
8.2 Microbiomes Key Players in China (2019-2020)
8.3 China Microbiomes Market Size by Type (2015-2020)
8.4 China Microbiomes Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Microbiomes Market Size (2015-2020)
9.2 Microbiomes Key Players in Japan (2019-2020)
9.3 Japan Microbiomes Market Size by Type (2015-2020)
9.4 Japan Microbiomes Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Microbiomes Market Size (2015-2020)
10.2 Microbiomes Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Microbiomes Market Size by Type (2015-2020)
10.4 Southeast Asia Microbiomes Market Size by Application (2015-2020)

11 INDIA

11.1 India Microbiomes Market Size (2015-2020)
11.2 Microbiomes Key Players in India (2019-2020)
11.3 India Microbiomes Market Size by Type (2015-2020)
11.4 India Microbiomes Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Microbiomes Market Size (2015-2020)
12.2 Microbiomes Key Players in Central & South America (2019-2020)
12.3 Central & South America Microbiomes Market Size by Type (2015-2020)
12.4 Central & South America Microbiomes Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 4D Pharma
  13.1.1 4D Pharma Company Details
  13.1.2 4D Pharma Business Overview
  13.1.3 4D Pharma Microbiomes Introduction
  13.1.4 4D Pharma Revenue in Microbiomes Business (2015-2020))
  13.1.5 4D Pharma Recent Development
13.2 Enterome BioScience
  13.2.1 Enterome BioScience Company Details
  13.2.2 Enterome BioScience Business Overview
  13.2.3 Enterome BioScience Microbiomes Introduction
  13.2.4 Enterome BioScience Revenue in Microbiomes Business (2015-2020)
  13.2.5 Enterome BioScience Recent Development
13.3 Evelo Biosciences
  13.3.1 Evelo Biosciences Company Details
  13.3.2 Evelo Biosciences Business Overview
  13.3.3 Evelo Biosciences Microbiomes Introduction
  13.3.4 Evelo Biosciences Revenue in Microbiomes Business (2015-2020)
  13.3.5 Evelo Biosciences Recent Development
13.4 Ferring
  13.4.1 Ferring Company Details
  13.4.2 Ferring Business Overview
  13.4.3 Ferring Microbiomes Introduction
  13.4.4 Ferring Revenue in Microbiomes Business (2015-2020)
  13.4.5 Ferring Recent Development
13.5 Osel
  13.5.1 Osel Company Details
  13.5.2 Osel Business Overview
  13.5.3 Osel Microbiomes Introduction
  13.5.4 Osel Revenue in Microbiomes Business (2015-2020)
  13.5.5 Osel Recent Development
13.6 Second Genome
  13.6.1 Second Genome Company Details
  13.6.2 Second Genome Business Overview
  13.6.3 Second Genome Microbiomes Introduction
  13.6.4 Second Genome Revenue in Microbiomes Business (2015-2020)
  13.6.5 Second Genome Recent Development
13.7 Seres Therapeutics
  13.7.1 Seres Therapeutics Company Details
  13.7.2 Seres Therapeutics Business Overview
  13.7.3 Seres Therapeutics Microbiomes Introduction
  13.7.4 Seres Therapeutics Revenue in Microbiomes Business (2015-2020)
  13.7.5 Seres Therapeutics Recent Development
13.8 Synlogic
  13.8.1 Synlogic Company Details
  13.8.2 Synlogic Business Overview
  13.8.3 Synlogic Microbiomes Introduction
  13.8.4 Synlogic Revenue in Microbiomes Business (2015-2020)
  13.8.5 Synlogic Recent Development
13.9 Synthetic Biologics and Vedanta Biosciences
  13.9.1 Synthetic Biologics and Vedanta Biosciences Company Details
  13.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
  13.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
  13.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2015-2020)
  13.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
13.10 Vedanta
  13.10.1 Vedanta Company Details
  13.10.2 Vedanta Business Overview
  13.10.3 Vedanta Microbiomes Introduction
  13.10.4 Vedanta Revenue in Microbiomes Business (2015-2020)
  13.10.5 Vedanta Recent Development
13.11 Rebiotix
  10.11.1 Rebiotix Company Details
  10.11.2 Rebiotix Business Overview
  10.11.3 Rebiotix Microbiomes Introduction
  10.11.4 Rebiotix Revenue in Microbiomes Business (2015-2020)
  10.11.5 Rebiotix Recent Development
13.12 ActoGeniX
  10.12.1 ActoGeniX Company Details
  10.12.2 ActoGeniX Business Overview
  10.12.3 ActoGeniX Microbiomes Introduction
  10.12.4 ActoGeniX Revenue in Microbiomes Business (2015-2020)
  10.12.5 ActoGeniX Recent Development
13.13 Enterologics
  10.13.1 Enterologics Company Details
  10.13.2 Enterologics Business Overview
  10.13.3 Enterologics Microbiomes Introduction
  10.13.4 Enterologics Revenue in Microbiomes Business (2015-2020)
  10.13.5 Enterologics Recent Development
13.14 Metabogen
  10.14.1 Metabogen Company Details
  10.14.2 Metabogen Business Overview
  10.14.3 Metabogen Microbiomes Introduction
  10.14.4 Metabogen Revenue in Microbiomes Business (2015-2020)
  10.14.5 Metabogen Recent Development
13.15 Metabiomics
  10.15.1 Metabiomics Company Details
  10.15.2 Metabiomics Business Overview
  10.15.3 Metabiomics Microbiomes Introduction
  10.15.4 Metabiomics Revenue in Microbiomes Business (2015-2020)
  10.15.5 Metabiomics Recent Development
13.16 Ritter Pharmaceuticals
  10.16.1 Ritter Pharmaceuticals Company Details
  10.16.2 Ritter Pharmaceuticals Business Overview
  10.16.3 Ritter Pharmaceuticals Microbiomes Introduction
  10.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2015-2020)
  10.16.5 Ritter Pharmaceuticals Recent Development
13.17 AvidBiotics
  10.17.1 AvidBiotics Company Details
  10.17.2 AvidBiotics Business Overview
  10.17.3 AvidBiotics Microbiomes Introduction
  10.17.4 AvidBiotics Revenue in Microbiomes Business (2015-2020)
  10.17.5 AvidBiotics Recent Development
13.18 Symberix
  10.18.1 Symberix Company Details
  10.18.2 Symberix Business Overview
  10.18.3 Symberix Microbiomes Introduction
  10.18.4 Symberix Revenue in Microbiomes Business (2015-2020)
  10.18.5 Symberix Recent Development
13.19 Miomics
  10.19.1 Miomics Company Details
  10.19.2 Miomics Business Overview
  10.19.3 Miomics Microbiomes Introduction
  10.19.4 Miomics Revenue in Microbiomes Business (2015-2020)
  10.19.5 Miomics Recent Development
13.20 Symbiotix Biotherapies
  10.20.1 Symbiotix Biotherapies Company Details
  10.20.2 Symbiotix Biotherapies Business Overview
  10.20.3 Symbiotix Biotherapies Microbiomes Introduction
  10.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2015-2020)
  10.20.5 Symbiotix Biotherapies Recent Development
13.21 MicroBiome Therapeutics LLC
  10.21.1 MicroBiome Therapeutics LLC Company Details
  10.21.2 MicroBiome Therapeutics LLC Business Overview
  10.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
  10.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2015-2020)
  10.21.5 MicroBiome Therapeutics LLC Recent Development
13.22 SciBac Inc
  10.22.1 SciBac Inc Company Details
  10.22.2 SciBac Inc Business Overview
  10.22.3 SciBac Inc Microbiomes Introduction
  10.22.4 SciBac Inc Revenue in Microbiomes Business (2015-2020)
  10.22.5 SciBac Inc Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Microbiomes Key Market Segments
Table 2. Key Players Covered: Ranking by Microbiomes Revenue
Table 3. Ranking of Global Top Microbiomes Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Microbiomes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gastrointestinal Microbiome
Table 6. Key Players of Genitourinary Microbiome
Table 7. Key Players of Skin Microbiome
Table 8. Key Players of Respiratory Microbiome
Table 9. Key Players of Other
Table 10. Global Microbiomes Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Microbiomes Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Microbiomes Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Microbiomes Market Share by Regions (2015-2020)
Table 14. Global Microbiomes Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Microbiomes Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Microbiomes Market Growth Strategy
Table 20. Main Points Interviewed from Key Microbiomes Players
Table 21. Global Microbiomes Revenue by Players (2015-2020) (Million US$)
Table 22. Global Microbiomes Market Share by Players (2015-2020)
Table 23. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiomes as of 2019)
Table 24. Global Microbiomes by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Microbiomes Product Solution and Service
Table 27. Date of Enter into Microbiomes Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 30. Global Microbiomes Market Size Share by Type (2015-2020)
Table 31. Global Microbiomes Revenue Market Share by Type (2021-2026)
Table 32. Global Microbiomes Market Size Share by Application (2015-2020)
Table 33. Global Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 34. Global Microbiomes Market Size Share by Application (2021-2026)
Table 35. North America Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Microbiomes Market Share (2019-2020)
Table 37. North America Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 38. North America Microbiomes Market Share by Type (2015-2020)
Table 39. North America Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 40. North America Microbiomes Market Share by Application (2015-2020)
Table 41. Europe Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Microbiomes Market Share (2019-2020)
Table 43. Europe Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Microbiomes Market Share by Type (2015-2020)
Table 45. Europe Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Microbiomes Market Share by Application (2015-2020)
Table 47. China Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 48. China Key Players Microbiomes Market Share (2019-2020)
Table 49. China Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 50. China Microbiomes Market Share by Type (2015-2020)
Table 51. China Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 52. China Microbiomes Market Share by Application (2015-2020)
Table 53. Japan Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Microbiomes Market Share (2019-2020)
Table 55. Japan Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Microbiomes Market Share by Type (2015-2020)
Table 57. Japan Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Microbiomes Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Microbiomes Market Share (2019-2020)
Table 61. Southeast Asia Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Microbiomes Market Share by Type (2015-2020)
Table 63. Southeast Asia Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Microbiomes Market Share by Application (2015-2020)
Table 65. India Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 66. India Key Players Microbiomes Market Share (2019-2020)
Table 67. India Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 68. India Microbiomes Market Share by Type (2015-2020)
Table 69. India Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 70. India Microbiomes Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Microbiomes Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Microbiomes Market Share (2019-2020)
Table 73. Central & South America Microbiomes Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Microbiomes Market Share by Type (2015-2020)
Table 75. Central & South America Microbiomes Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Microbiomes Market Share by Application (2015-2020)
Table 77. 4D Pharma Company Details
Table 78. 4D Pharma Business Overview
Table 79. 4D Pharma Product
Table 80. 4D Pharma Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 81. 4D Pharma Recent Development
Table 82. Enterome BioScience Company Details
Table 83. Enterome BioScience Business Overview
Table 84. Enterome BioScience Product
Table 85. Enterome BioScience Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 86. Enterome BioScience Recent Development
Table 87. Evelo Biosciences Company Details
Table 88. Evelo Biosciences Business Overview
Table 89. Evelo Biosciences Product
Table 90. Evelo Biosciences Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 91. Evelo Biosciences Recent Development
Table 92. Ferring Company Details
Table 93. Ferring Business Overview
Table 94. Ferring Product
Table 95. Ferring Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 96. Ferring Recent Development
Table 97. Osel Company Details
Table 98. Osel Business Overview
Table 99. Osel Product
Table 100. Osel Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 101. Osel Recent Development
Table 102. Second Genome Company Details
Table 103. Second Genome Business Overview
Table 104. Second Genome Product
Table 105. Second Genome Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 106. Second Genome Recent Development
Table 107. Seres Therapeutics Company Details
Table 108. Seres Therapeutics Business Overview
Table 109. Seres Therapeutics Product
Table 110. Seres Therapeutics Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 111. Seres Therapeutics Recent Development
Table 112. Synlogic Business Overview
Table 113. Synlogic Product
Table 114. Synlogic Company Details
Table 115. Synlogic Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 116. Synlogic Recent Development
Table 117. Synthetic Biologics and Vedanta Biosciences Company Details
Table 118. Synthetic Biologics and Vedanta Biosciences Business Overview
Table 119. Synthetic Biologics and Vedanta Biosciences Product
Table 120. Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 121. Synthetic Biologics and Vedanta Biosciences Recent Development
Table 122. Vedanta Company Details
Table 123. Vedanta Business Overview
Table 124. Vedanta Product
Table 125. Vedanta Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 126. Vedanta Recent Development
Table 127. Rebiotix Company Details
Table 128. Rebiotix Business Overview
Table 129. Rebiotix Product
Table 130. Rebiotix Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 131. Rebiotix Recent Development
Table 132. ActoGeniX Company Details
Table 133. ActoGeniX Business Overview
Table 134. ActoGeniX Product
Table 135. ActoGeniX Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 136. ActoGeniX Recent Development
Table 137. Enterologics Company Details
Table 138. Enterologics Business Overview
Table 139. Enterologics Product
Table 140. Enterologics Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 141. Enterologics Recent Development
Table 142. Metabogen Company Details
Table 143. Metabogen Business Overview
Table 144. Metabogen Product
Table 145. Metabogen Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 146. Metabogen Recent Development
Table 147. Metabiomics Company Details
Table 148. Metabiomics Business Overview
Table 149. Metabiomics Product
Table 150. Metabiomics Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 151. Metabiomics Recent Development
Table 152. Ritter Pharmaceuticals Company Details
Table 153. Ritter Pharmaceuticals Business Overview
Table 154. Ritter Pharmaceuticals Product
Table 155. Ritter Pharmaceuticals Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 156. Ritter Pharmaceuticals Recent Development
Table 157. AvidBiotics Company Details
Table 158. AvidBiotics Business Overview
Table 159. AvidBiotics Product
Table 160. AvidBiotics Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 161. AvidBiotics Recent Development
Table 162. Symberix Company Details
Table 163. Symberix Business Overview
Table 164. Symberix Product
Table 165. Symberix Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 166. Symberix Recent Development
Table 167. Miomics Company Details
Table 168. Miomics Business Overview
Table 169. Miomics Product
Table 170. Miomics Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 171. Miomics Recent Development
Table 172. Symbiotix Biotherapies Company Details
Table 173. Symbiotix Biotherapies Business Overview
Table 174. Symbiotix Biotherapies Product
Table 175. Symbiotix Biotherapies Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 176. Symbiotix Biotherapies Recent Development
Table 177. MicroBiome Therapeutics LLC Company Details
Table 178. MicroBiome Therapeutics LLC Business Overview
Table 179. MicroBiome Therapeutics LLC Product
Table 180. MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 181. MicroBiome Therapeutics LLC Recent Development
Table 182. SciBac Inc Company Details
Table 183. SciBac Inc Business Overview
Table 184. SciBac Inc Product
Table 185. SciBac Inc Revenue in Microbiomes Business (2015-2020) (Million US$)
Table 186. SciBac Inc Recent Development
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Microbiomes Market Share by Type: 2020 VS 2026
Figure 2. Gastrointestinal Microbiome Features
Figure 3. Genitourinary Microbiome Features
Figure 4. Skin Microbiome Features
Figure 5. Respiratory Microbiome Features
Figure 6. Other Features
Figure 7. Global Microbiomes Market Share by Application: 2020 VS 2026
Figure 8. Testing Case Studies
Figure 9. Treatment Case Studies
Figure 10. Diagnosis Case Studies
Figure 11. Technology Platform Case Studies
Figure 12. Probiotics Case Studies
Figure 13. Other Case Studies
Figure 14. Microbiomes Report Years Considered
Figure 15. Global Microbiomes Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Microbiomes Market Share by Regions: 2020 VS 2026
Figure 17. Global Microbiomes Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Microbiomes Market Share by Players in 2019
Figure 20. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiomes as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Microbiomes Revenue in 2019
Figure 22. North America Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Microbiomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed